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This review addresses the essential questions to consider when
attempting to phase a new crystal structure using molecular
replacement. Sequence matching can suggest whether there is
a suitable three-dimensional model available, but it is also
important to analyse the model in order to ﬁnd its likely
oligomeric state and to establish whether there are likely to be
domain movements. Once a solution has been found it must be
reﬁned, which can be challenging for low-homology models.
There is a detailed discussion of structures used as examples
for CCP4 tutorials.
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1. Introduction
Most of the readers of this volume are probably structural
biologists, with a bias towards biology rather than structure.
The discipline of crystallography is now fairly mature and can
provide semi-automated tools to determine a structure
without requiring a detailed understanding of the technical
procedures. Users want to understand how a particular
macromolecule ﬁts into the machinery of a living cell and
knowledge of its three-dimensional geometry can illuminate
this.
However, to obtain such a model we need ﬁrstly to under-
stand the known biochemistry, secondly to obtain protein,
grow a crystal and collect observable intensities, and thirdly
either to determine some experimental phases to allow the
ﬁrst model to be built or to use molecular-replacement (MR)
techniques to position a known model in the new cell and thus
generate initial phases. The ﬁnal stage is to reﬁne this model to
one most consistent with the observed data.
1.1. Tutorials
The examples I will discuss are used for molecular-
replacement tutorial material available from CCP4.
Alexei Vagin and Andrey Lebedev have prepared a tutorial
which is available as part of the MOLREP download from
http://www.ysbl.york.ac.uk/~alexei/molrep.html#installation.
Martyn Winn and I prepared extra material for a workshop
in China. It is available at http://www.ccp4.ac.uk/courses/
china06/tutorials/mr_tutorial_ﬁrst.html and http://www.ccp4.ac.uk/
courses/china06/tutorials/mr_tutorial_advanced.html.
2. The known biochemistry
It is safe to assume that all structural projects begin with
knowledge of the sequence of the molecule under study and
hence its molecular weight. The ﬁrst step in determining a
structure is to search the available databases to see what isalready known; without an existing
three-dimensional model molecular
replacement is not an option for struc-
ture solution and the experimental
design will require the measurement of
extra sets of observed intensities for the
determination of phases.
There is now a wealth of sequence
information available for many organ-
isms and excellent bioinformatics tools
for searching these sequence databases.
Likely homologous models can be
gleaned by matching the sequence to
those of known structures. There are
many web-based tools for this, several
of which are described by other contri-
butors. I will illustrate the approach
using the MSDtarget tool from the
European Bioinformatics Institute
(EBI) Macromolecular Structure Divi-
sion (MSD; http://www.ebi.ac.uk/msd).
This returns a list of targets and a pair-
wise alignment for all likely models.
More sophisticated multiple sequence-
alignment tools are described in Barton
(2008) and Schwarzerbacher et al.
(2008).
There may well be several models
available and it is possible to learn more
about your system by analysing and
comparing these. Again there are many
tools available, but I will use the EBI
MSD tool MSDfold, developed by
Eugene Krissinel (Krissinel & Henrick,
2004). This matches the secondary-
structure elements of all models to the
selected target and aligns them. (It may
well also ﬁnd other examples with
similar folds but lower sequence iden-
tity not found by MSDtarget.) When
there is low sequence homology, the
secondary-structure matching may give
research papers
18 Dodson   Molecular replacement Acta Cryst. (2008). D64, 17–24
Figure 1
Matching the S100 sequence against the EBI
databases. (a) Some of the matching sequences
found by the MSDtarget pairwise alignment.
Those with associated three-dimensional
models are shown in green. (b) The pairwise
alignment for one of the models, 1irj. (c)T h e
overlap, based on one chain only, of the ﬁnal
S100 dimer model, 1e8a, onto the 1irj dimer.
The two chains of the S100 dimer are shown in
green and blue and those of the 1irj dimer in
yellow and tan. Clearly, the second chains do
not match well. (d) The overlap of 1e8a onto
the 1mho dimer using the same colour scheme.
Although the matched chains do not ﬁt so well,
the relative orientation of the monomers is
closer than that for 1irj.a slightly different sequence alignment to that based on
sequence alone.
It is useful to inspect the overlap of these aligned models.
This can reveal domain movement between one model and
another and unless this is treated properly it can make it very
difﬁcult to obtain any MR solution. The aligned domains can
be used as input for the existing MR programs that accept
multiple overlapping copies
It is also important to follow up clues to the likely biological
entity, e.g. does this protein form an oligomer? The EBI tool
MSDpisa analyses this and returns a set of coordinates for the
assembly, as well as reporting the buried surface area,
hydrogen bonds and so on (Krissinel & Henrick, 2007).
2.1. Examples
2.1.1. Human S100 A12 (S100). This structure has been
deposited with PDB code 1e8a (Moroz et al., 2001). Some of
the MSDtarget output obtained from the S100 sequence
search is given in Fig. 1(a); Fig. 1(b) shows the pairwise
matches. I will discuss models 1irj (41% sequence identity)
and 1mho (39% sequence identity).
MSDpisa indicates that both models are likely to be dimers
with buried surface areas of 1282 and 1321 A ˚ 2, respectively.
Figs. 1(c) and 1(d) show the alignment of these dimers. It is
clear that their dimer interfaces are slightly different. A post
mortem comparison of these models with the S100 structure
shows that the root-mean-square (r.m.s.) difference in C

positions of the monomers is 0.88 A ˚ (1irj) and 1.23 A ˚ (1mho),
whilst for the 1irj dimer it is 2.64 A ˚ and for the 1mho dimer it
is 1.68 A ˚ . If searching with a monomer 1irj would prove the
better model, but if searching with a dimer the 1mho example
is better. In practice, it is sensible to try all available models in
all likely oligomeric states.
2.1.2. Sugar phosphotase in the closed form. This structure
has been deposited with PDB code 1tj3 (Fieulaine et al., 2005).
There are several models with 100% sequence identity.
However, there is clearly a hinged domain movement; the
r.m.s. distance for C
 atoms between two of these models, 2d2v
and 1s2o, is 2.4 A ˚ . After overlapping the models (Figs. 2a and
2b), it is clear that there are two domains, one made up of
residues 1–73 and 163–244, and another consisting of residues
74–162. In such a case it is necessary to search for a solution
with each domain separately.
2.1.3. Insulin. At high concentration and in the presence of
a metal, insulin exists as a hexamer made up of three dimers
each with two chemically identical monomers (Fig. 3). There
are many crystal structures of insulin hexamers, some with one
or more hexamers in the crystal asymmetric unit and some
containing monomers or dimers, with the hexamer generated
by crystal symmetry (Baker et al., 1988). An analysis of the
contents of the asymmetric unit may suggest the likely stoi-
chiometry and a self-rotation function may suggest the nature
of the noncrystallographic symmetry. However, the inter-
actions between crystallographic and noncrystallographic
symmetry can become very complex.
2.1.4. Family 2 carbohydrate esterase (CE2). This is a 345-
residue protein solved by MR from a low-homology model.
Some experimental phase information was also obtained from
the anomalous scattering power of two Se atoms.
The MR solution was veriﬁed by checking it against the
known selenium positions.
2.1.5. hypF. This crystal structure is of the prokaryotic
hydrogenase maturation factor hypF acylphosphatase-like
domain with a bound anion (Rosano et al., 2002). It was solved
from experimental phases using a Hg derivative (the images
were used for the data-processing tutorial described in http://
www.mrc-lmb.cam.ac.uk/harry/imosﬂm/tutorial.html). It was
later reﬁned against 1.3 A ˚ data and deposited with PDB code
1gxu.
It can also be solved straightfor-
wardly by MR using the model 1w2i
with 38% sequence identity. I have
included it to illustrate how the phase
reﬁnement carried out using the
program ACORN (Yao et al., 2005) can
improve the map and reduce the bias
towards the initial model.
3. Planning the crystallography
While studying the bioinformatics
information based on sequence, one
hopes that a large crystal of the protein
of interest is growing. The type of
diffraction measurements required to
solve the X-ray structure will depend to
some extent on the chosen solution
method. For experimental phasing, it is
necessary to have a detectable sub-
structure incorporated into the crystal,
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Figure 2
The overlap of two models with 100% sequence identity to 1tj3. 2d2v is shown in green and 1s2o in
blue. There is a hinged domain movement about residues 78–79 and 163–164. (a) The overlap based
on residues 1–78 and 164–244. (b) The overlap based on residues 79–163.either anomalous scatterers or heavy atoms. Accurate
measurements of the differences arising from that substruc-
ture to a limited resolution are needed to ﬁrst position the
substructure and then estimate experimental phases. For
phase extension and reﬁnement, we need the highest obser-
vable resolution plus complete low-resolution data. To solve
the molecular replacement, a single complete data set to
modest resolution is enough, but again the MR solution model
must be reﬁned and this is much more straightforward with
higher resolution data.
If possible, it helps to use both the MR solution model and
experimental phase information during the reﬁnement step.
These phases will not be biased towards the initial model and
so can help when rebuilding and act as additional restraints to
speed up reﬁnement (Pannu et al., 1998).
As an aside, it is important to remember that when
combining information from two (or more) diffraction
experiments it is essential that the data sets are indexed
according to the same convention and that the MR model and
the substructure are positioned relative to the same origin.
There is discussion of these conventions in the CCP4
program documentation. See http://www.ccp4.ac.uk/dist/
html/reindexing.html and http://www.ccp4.ac.uk/dist/html/
alternate_origins.html.
A simple way to achieve this is to calculate phases from the
MR model and use these to produce anomalous or isomor-
phous difference maps with the data to be used for estimating
experimental phases. If there are already more than one set of
phases available, then the Clipper utility Phase Comparison
(Cowtan, 2003) checks consistency and makes the appropriate
corrections for any required origin shift or change of hand.
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Figure 4
Quality indicators for the S100 intensity data used to solve the structure.
These are all output from the TRUNCATE program. (a) The fourth
moment plot of hEi for acentric data. This is approximately 2.0 across the
whole resolution range, showing that the crystal is not seriously twinned.
(b) The cumulative intensity distribution. The observed values agree well
with the expected theoretical values. (c) An illustration of the anisotropic
nature of the intensity distribution. The mean amplitude along the third
axis is much weaker than that along the ﬁrst and second.
Figure 3
The insulin hexamer. Each of the 12 chains is shown in a different colour.
The monomer unit is made up of two chains. Different structures have
one monomer in the asymmetric unit (space groups P6322, H32, P321), a
dimer in the asymmetric unit (H3, P213), a trimer (P41213) or a hexamer
(P21)3.1. Assessing the quality of diffraction data
The diffraction experiment will reveal the unit-cell para-
meters and point group of our new crystal form. As for any
X-ray study, it is important to assess the quality of the
experimental data. It should be complete at low resolution and
extend to the highest resolution available to help the reﬁne-
ment procedures. The data-reduction software gives some
analysis of other problems which may arise. Is the crystal
twinned? Is the diffraction very anisotropic? Fig. 4 shows
various plots taken from the output of the TRUNCATE
program which may indicate problems. There is a discussion of
indicators of data quality at http://www.ccp4.ac.uk/dist/html/
pxmaths/bmg10.html and of the effects of twinning at
http://www.ccp4.ac.uk/dist/html/twinning.html. The program
SFCHECK (Vaguine et al., 1999) is another tool for data
analysis. As well as detecting anisotropy and possible twin-
ning, it reports noncrystallographic translation.
3.2. Determining the space group
It is often not possible to assign a space group unambigu-
ously at this stage. Absences along particular axes indicate
screw axes, e.g. space group P21 will have absences for all 0k0
reﬂections where k is odd. However, any pseudo-translation
vector (x, 0.5, z) will also cause the same reﬂections to have
very weak intensities. There are other space groups where the
enantiomorph generates the same systematic absences.
Examples are space groups P41 and P43 or P61 and P65. The
MR search should settle this uncertainty since one of the
possible space groups should score signiﬁcantly higher than
any of the alternatives.
3.3. What can we estimate from sequence and diffraction?
From the volume of the crystal asymmetric unit and the
molecular weight of the protein, it is possible to estimate how
many independent copies of the molecule under investigation
are likely to be in the asymmetric unit. If there is more than
one it is important to check whether there is a noncrystallo-
graphic symmetry element or a noncrystallographic transla-
tion vector relating them. Both these can be predicted from
the X-ray data alone. If there is extra symmetry such as a
noncrystallographic twofold axis, the self-rotation function
may reveal it (Figs. 5a and 5b). However, this can be masked
by crystal symmetry and be very confusing to interpret!
Insulin studies illustrate this: the intersecting twofold and
threefold axes of the hexamer are sometimes crystallographic
and sometimes not and the asymmetric unit can consist of
monomers, dimers, trimers or hexamers. There are examples
of structures in many different space groups, e.g. H32 and
P6322 with a monomer in the asymmetric unit, H3 and P213
with a dimer, P321 with three molecules in the asymmetric
unit, a trimer on the twofold axis and a monomer at the 32
centre, and P21 with the whole hexamer in the asymmetric
unit.
If there is a noncrystallographic translation the 4 A ˚ native
Patterson will have a large off-origin peak at the position
representing this translation. Unlike noncrystallographic
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Figure 5
Self-rotation sections for different  values calculated using MOLREP.( a)  = 180  sections for insulin data in space group P321. The crystallographic
threefold axes are the maximum. The second peak on the  = 180  section marked in red is generated by a noncrystallographic twofold axes of symmetry.
The interaction of crystallographic and noncrystallographic symmetry generates many additional features. (b)  = 180  sections for S100 data in space
group H32. The noncrystallographic twofold axis of symmetry is marked in red. It is not a well deﬁned peak and is distorted by its interaction with the
crystallographic symmetry.rotations, noncrystallographic translations are not particularly
useful in structure determination. In fact, they introduce
awkward structure-factor correlations that are not currently
accounted for and can make structures difﬁcult to reﬁne.
4. Molecular-replacement techniques and software
The methodology is discussed by other authors in this issue.
5. Verifying the solution
As an aside, remember that it can be difﬁcult to compare
solutions from different programs, since the calculated
amplitudes will be the same irrespective of any crystal-
lographic symmetry operator applied to the solution or
alternate choice of unit-cell origin. If phases are calculated
from both models, the Clipper utility Phase Comparison will
indicate whether the solutions are consistent after taking into
account the choice of origin.
5.1. Space-group check
The MR search programs can be run in the several alternate
space groups consistent with the point group. A good indicator
is if there is a signiﬁcantly better result in one space group
than the others. (Different software uses different scoring
functions, but all require a strong correlation between the
observed and calculated amplitudes.)
5.2. Chemical sense
We need to check whether the model makes chemical sense.
Are there many clashes between symmetry copies? Is the
biological entity sensible? (This can be somewhat tricky to
check from the MR solution alone; many MR search programs
will position the correct number of molecules but not cluster
them in the unit cell. Once again MSDpisa can be used to
select the best assembly from the solution.) If there are several
molecules in the asymmetric unit are they consistent with the
self-rotation function? If you have some extra information
such as possible positions for Se or S atoms, is this model
consistent with it? (Remember to consider alternate origins
and hands.)
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Figure 6
The ﬁrst maximum-likelihood weighted electron-density map for S100
from the 1irj solution after ten initial rounds of reﬁnement. The model
had been truncated to remove many of the side chains. R and Rfree had
fallen from 47.1% and 47.2% to 34.4% and 44.4%, respectively. Although
the map is of poor quality, there is clear density for the Ile79 side chain.
Figure 7
Electron density maps for hypF using 1.3 A ˚ data. (a) The ﬁrst maximum-
likelihood-weighted map showing the electron density near Pro85. After
ten cycles of reﬁnement, R and Rfree have fallen from 55.2% and 55.8% to
47.2% and 48.6%, respectively. (b)T h eACORN map for Pro85 after
automated phase reﬁnement.5.3. Can the model be refined?
The usual check is that the solution model generates
structure amplitudes which agree with the observed ones.
Initial R values always seem to be high (typically R/free R of
55%/55% for me), but correct solutions will (usually!) reﬁne
automatically to an R/free R of about 40%/45%. The most
encouraging veriﬁcation is the electron density: if you can see
features in the maps which are not part of the model, then the
solution is probably substantially correct (Fig. 6).
6. Refinement tricks and bias elimination
There are still intractable problems in progressing from an
initial MR solution to a ﬁnal model which reﬂects the differ-
ences between the initial search molecule and that under
investigation. There is no foolproof way of recognizing where
the two models will differ and the initial maps will tend to
mirror the partially incorrect input structure, especially if
there is a paucity of experimental data. It is still sometimes
necessary to rebuild the structure slowly into a series of
weighted difference maps.
If the resolution is sufﬁcient, automated rebuilding methods
combined with maximum-likelihood weighted reﬁnement can
be very successful, rebuilding and correcting most of the
molecule. ARP/wARP (described by Cohen et al., 2008) and
RESOLVE (Terwilliger, 2002) are well established methods
for automated rebuilding.
If the data resolution extends to 1.7 A ˚ or better, density-
modiﬁcation procedures such as those programmed into
ACORN can eliminate bias quickly and give excellent starting
maps (Figs. 7a and 7b).
6.1. Ingenuity: use all your crystallographic knowledge
There are many interesting reports of structure solution
which ingeniously combine different crystallographic tech-
niques for obtaining the ﬁnal model. I list some of them here
for reference.
(i) Most structures include some weak anomalous scatterers
such as S atoms. Providing the anomalous differences for the
data set have been retained, it is easy to produce an ‘anom-
alous difference map’ using the measured anomalous differ-
ences and the phases calculated from the MR model. A peak
search of such a map may (depending on the data quality) ﬁnd
the anomalous scattering sites. If so, this is very encouraging
and can position some side chains, typically Cys and Met,
unambiguously. It may indeed be possible to calculate
experimental phases from these anomalous differences.
(ii) If there is more than one copy of the molecule in the
asymmetric unit it is possible (and easy within the graphics
program Coot; Emsley & Cowtan, 2004) to display averaged
density, which is often easier to interpret. A single copy of the
molecule is rebuilt into the averaged map and then copied
back to the other positions. An extension of this method was
used by Keller et al. (2006) to solve a structure with very low
homology and near perfect noncrystallographic fourfold
rotational symmetry. They used the phases based on the model
to 5 A ˚ only and successfully used density modiﬁcation to
extend and average phases to the resolution limit.
(iii) Victoria Money and colleagues in York have combined
information from experimental phasing to verify a low-
homology MR solution and to speed up rebuilding of a
carbohydrate esterase (CE2; private communication). Initial
phases had been calculated based on two Se atoms for 340
residues. These were not sufﬁcient to give an interpretable
map. The MR solution was also somewhat unclear, but the
positions of the selenium-containing residues were consistent
with those deduced from the anomalous data measurements.
The truncated MR model was reﬁned with the experimental
phases as restraints and although this too generated a poor
map, it was possible to position many of the side chains and to
kick-start further reﬁnement and rebuilding (Fig. 8).
(iv) If the model is ﬂexible with several domains, it can help
to break up any solution based on the whole model into
domains and carry out a rigid-body reﬁnement of these frag-
ments to improve the initial ﬁt. Such an approach is reported
in Martinez-Fleites et al. (2005).
7. Conclusions
As more and more structural information becomes available,
greatly improved bioinformatics tools are being developed to
analyse and display it. Although molecular replacement is
becoming automated, there is still a place for crystallographic
and biological insight. In some cases this can be challenging;
the interaction of different symmetry elements is often
extremely complex. The ﬁnal frontier of automating reﬁne-
ment of MR models has still not been reached.
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Figure 8
CE2 experimentally phased electron-density maps with phases based on
the weak Se anomalous signal. The molecular-replacement solution is
superposed. The broken density for residue Trp239A clearly veriﬁes the
MR solution.This review rests heavily on the work of others. It borrows
from tutorial material prepared by Airlie McCoy, Alexei
Vagin, Andrey Lebedev and Martyn Winn. Members of the
York Structural Biology Laboratory have provided data and
valuable discussions. In particular, I would like to thank Olga
Morez, Carlos Martinez-Fleites, David Lawson, Carmelo
Rosano and Victoria Money for providing examples. Liz
Potterton helped to prepare the ﬁgures using CCP4MG
(Potterton et al., 2004).
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